Quantive Intelligence provides biometrics, analytics, strategy, and regulatory services for life sciences clinical development.
Founded in 2026 in Pennsylvania, Quantive Intelligence provides decision-sciences services to pharmaceutical and biotechnology companies across clinical development. Its offerings include biostatistics, programming, data management, regulatory submissions, consulting, and FSP staffing. Formed by Graham Partners through the acquisitions of TechData Service Company, LLC, LLX Solutions, LLC, and R Square Technology, Inc., the company is led by CEO Samir Shah. It plans to invest in AI tools, expand R programming services, and develop commercial and recruiting functions.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in